Epstein Barr virus vaccine (Australian Centre for Vaccine Development (ACVD)/Henderson Morley)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameEpstein Barr virus vaccine (Australian Centre for Vaccine Development (ACVD)/Henderson Morley)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsEpstein-Barr Virus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia and New ZealandUnited Kingdom

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAustralian Centre for Vaccine Development

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAustralian Centre for Vaccine Development Henderson Morley plc

Active IndicationsN/A

Inactive IndicationsEpstein-Barr Virus Infections

Other Information

ATC CodeN/A